University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Improving Health Outcomes for Women Living With HIV

Not Applicable

Completed

Conditions: HIV/AIDS

Interventions: Behavioral: Peer Navigation

First Posted Date: 2018-05-15

Last Posted Date: 2019-11-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 113

Registration Number: NCT03525340

Locations: 🇧🇷
Santa Casa Medical School, São Paulo, Brazil

UCSF College Health Study on Contraceptive Training and Education at Community Colleges

Not Applicable

Active, not recruiting

Conditions: Contraception

Interventions: Behavioral: Contraceptive Training and Education
Behavioral: Placebo Nutrition Education

First Posted Date: 2018-05-09

Last Posted Date: 2023-10-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 2086

Registration Number: NCT03519685

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Myocardial Injury and Intraoperative Tissue Oximetry in Patients Undergoing Spine Surgery

Completed

Conditions: Hypoxia
Myocardial Injury
Surgery--Complications

First Posted Date: 2018-05-08

Last Posted Date: 2020-06-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 70

Registration Number: NCT03518372

Locations: 🇺🇸
UCSF Medical Center, San Francisco, California, United States

Enhanced Stress Resilience Training for Residents

Not Applicable

Completed

Conditions: Mindfulness
Stress
Cognitive Change

Interventions: Behavioral: Enhanced Stress Resilience Training (ESRT)
Behavioral: Active Control

First Posted Date: 2018-05-08

Last Posted Date: 2022-02-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 45

Registration Number: NCT03518359

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Enhanced Stress Resilience Training for Faculty

Not Applicable

Completed

Conditions: Burnout, Professional

Interventions: Behavioral: Enhanced Stress Resilience Training for Faculty Physicians

First Posted Date: 2018-05-04

Last Posted Date: 2021-10-26

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 48

Registration Number: NCT03516877

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial

Phase 3

Completed

Conditions: Opioid Use
Thoracic Diseases
Postoperative Pain

Interventions: Drug: Bupivacaine Injection
Drug: Liposomal bupivacaine

First Posted Date: 2018-04-26

Last Posted Date: 2021-06-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 91

Registration Number: NCT03508830

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Media, Morphokinetics, and Mosaicism

Not Applicable

Completed

Conditions: Embryonic Mosaicism
Embryo Morphokinetics
Embryo Culture Media
Infertility

Interventions: Device: EmbryoScope Plus
Other: SAGE MEDIA
Other: GLOBAL MEDIA

First Posted Date: 2018-04-20

Last Posted Date: 2022-12-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 200

Registration Number: NCT03503877

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Stage IV Prostate Adenocarcinoma AJCC v7
Castration-Resistant Prostate Carcinoma
Castration Levels of Testosterone
PSA Progression

Interventions: Drug: Apalutamide
Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2018-04-19

Last Posted Date: 2024-02-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 26

Registration Number: NCT03503344

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Treatment of Asian Flushing Syndrome With Topical Alpha Agonists

Early Phase 1

Completed

Conditions: Flushing
Alcohol-Related Disorders
Aldehyde Dehydrogenase Deficiency

Interventions: Drug: Placebo Vehicle Gel
Drug: Brimonidine Tartrate

First Posted Date: 2018-04-13

Last Posted Date: 2020-05-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT03497442

Locations: 🇺🇸
UC, San Francisco, San Francisco, California, United States

Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury

Phase 1

Completed

Conditions: Subarachnoid Hemorrhage
Ischemic Stroke
Subdural Hematoma
Traumatic Brain Injury
Intracerebral Hemorrhage
Fever

Interventions: Drug: Bromocriptine 5 MG
Drug: Acetaminophen 650 MG

First Posted Date: 2018-04-12

Last Posted Date: 2021-06-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 47

Registration Number: NCT03496545

Locations: 🇺🇸
Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States
🇺🇸
University of California, San Francisco Medical Center - Parnassus, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy